The global veterinary imaging market size was USD 1.83 billion in 2023, calculated at USD 1.96 billion in 2024 and is expected to be worth around USD 3.86 billion by 2034. The market is slated to expand at 7.02% CAGR from 2024 to 2034
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Veterinary Imaging Market
5.1. COVID-19 Landscape: Veterinary Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Veterinary Imaging Market, By Product
8.1. Veterinary Imaging Market Revenue and Volume, by Product, 2024-2034
8.1.1. X-ray
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Ultrasound
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. MRI
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. CT Imaging
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Video Endoscopy
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Veterinary Imaging Market, By Solutions
9.1. Veterinary Imaging Market Revenue and Volume, by Solutions, 2024-2034
9.1.1. Equipment
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Accessories/Consumables
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. PACS
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Veterinary Imaging Market, By Animal Type
10.1. Veterinary Imaging Market Revenue and Volume, by Animal Type, 2024-2034
10.1.1. Small Animals
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Large Animals
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 11. Global Veterinary Imaging Market, By Application
11.1. Veterinary Imaging Market Revenue and Volume, by Application, 2024-2034
11.1.1. Orthopedics And Traumatology
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Neurology
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1.3. Respiratory
11.1.3.1. Market Revenue and Volume Forecast (2021-2034)
11.1.4. Cardiology
11.1.4.1. Market Revenue and Volume Forecast (2021-2034)
11.1.5. Dental Application
11.1.5.1. Market Revenue and Volume Forecast (2021-2034)
11.1.6. Others
11.1.6.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 12. Global Veterinary Imaging Market, By End-use
12.1. Veterinary Imaging Market Revenue and Volume, by End-use, 2024-2034
12.1.1. Veterinary Hospitals & Clinics
12.1.1.1. Market Revenue and Volume Forecast (2021-2034)
12.1.2. Other
12.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 13. Global Veterinary Imaging Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.1.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.1.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.1.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.1.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.1.6.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.1.6.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.1.6.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.1.7.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.1.7.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.1.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.1.7.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.2.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.2.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.6.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.2.6.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.2.7. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.8. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.9.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.2.9.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.2.10. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.11. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.12.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.2.12.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.2.12.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.13. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.14.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.2.14.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.2.14.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.15. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.3.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.3.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.6.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.3.6.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.7. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.8.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.3.8.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.9. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.10.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.3.10.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.3.10.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.10.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.11.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.3.11.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.3.11.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.11.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.4.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.4.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.6.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.4.6.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.7. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.8.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.4.8.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.9. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.10.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.4.10.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.4.10.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.10.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.11.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.4.11.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.4.11.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.11.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.5.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.5.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.5.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.5.6.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.5.6.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.5.7. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.5.8.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)
13.5.8.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)
13.5.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.5.8.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
Chapter 14. Company Profiles
14.1. IMV Imaging
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Shenzhen Mindray Animal Medical Technology, Co., Ltd.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Canon Medical Systems Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Hallmarq Veterinary Imaging
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. FUJIFOLD Holdings America Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Midmark Corporation
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. GE Healthcare
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Mars, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. ESAOTE SPA
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. IDEXX Laboratories
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client